#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in liver Cutaneous T-cell lymphoma Trigeminal neuralgia Cutaneous T-cell lymphoma stage I Lupus nephritis Acquired ATTR amyloidosis Niemann-Pick disease Hepatocellular carcinoma Essential thrombocythaemia Acute hepatic failure Adrenocortical carcinoma Aplastic anaemia Follicular lymphoma stage II Haemophagocytic lymphohistiocytosis Oesophageal achalasia More trials…

    Learn about Rare Diseases

    Angiosarcoma – Basic Information Glomerulonephritis membranoproliferative – Basic Information Alagille syndrome – Diagnostics Leukoencephalopathy – Life with Disease Indolent systemic mastocytosis – Treatment Rhabdoid tumour Hereditary ataxia – Life with Disease Immunodeficiency congenital – Diagnostics Osteosarcoma metastatic – Treatment Arterial tortuosity syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    DICLOFENAC POTASSIUM Emiplacel Yttrium-90 Mrna-4157 Dorocubicel Fenofibrate L-METHIONINE Febuxostat Hemihydrate Ketoprofen GSKVX000000048110 Secale Cereale Spartalizumab GOLD SODIUM THIOSULFATE [Al[18F]F]Fapi-74 Efzofitimod Bay 3018250 WEF-001 Amifostine Thiol Enlicitide Chloride Topotecan Hydrochloride More therapies…

    Learn about Your Condition

    Thalassaemia alpha Low cardiac output syndrome B-cell lymphoma Cholangiosarcoma Multiple system atrophy Cardiac amyloidosis Craniocerebral injury Von Willebrand's disease Cholangiocarcinoma Penile squamous cell carcinoma Coeliac disease Testis cancer Nervous system disorder Acute cardiac event Rabies More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Conjunctivitis allergic

  • Study on the Effectiveness and Safety of a Grass and Juniperus Oxycedrus Allergy Vaccine for Patients with Allergic Rhinitis or Rhinoconjunctivitis with or without Mild Asthma

    Recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Rhinitis allergic
    • Seasonal allergy
    Investigated Drugs:
    • Allergen Extract From Dactylis Glomerata Pollen, Glutaraldehyde-Modified
    • Allergen Extract From Lolium Perenne Pollen, Glutaraldehyde-Modified
    • Allergen Extract From Phleum Pratense Pollen, Glutaraldehyde-Modified
    Spain

  • Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen

    Recruiting

    3 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • 12 Grass Pollen Mixture
    • Grass Pollen Allergen Extract Modified With Glutaraldehyde And Adsorbed To L-Tyrosine
    • Histamine Dihydrochloride
    Bulgaria Czechia Germany Lithuania Poland Romania +1

  • Clinical Trial of Dermatophagoides farinae, Dermatophagoides pteronyssinus, and Blomia tropicalis Allergen Extracts in Patients with Allergic Rhinitis/Rhinoconjunctivitis With or Without Mild Asthma

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Conjunctivitis allergic
    • Mite allergy
    • Rhinitis allergic
    Investigated Drugs:
    • ALLERGEN EXTRACTS
    • Dermatophagoides Farinae Allergoid, Glutaraldehyde-Modified
    • Dermatophagoides Pteronyssinus Allergoid, Glutaraldehyde-Modified
    Spain

  • Dermatophagoides farinae, Dermatophagoides pteronyssinus, and Lepidoglyphus destructor Immunotherapy for Allergic Rhinitis and Rhinoconjunctivitis in Patients With or Without Mild Asthma

    Not yet recruiting

    3 1
    Investigated Drugs:
    • ALLERGEN EXTRACTS
    • Dermatophagoides Farinae Allergoid, Glutaraldehyde-Modified
    • Dermatophagoides Pteronyssinus Allergoid, Glutaraldehyde-Modified
    Spain

  • A Study Comparing Tacrolimus and Ciclosporin Eye Drops for Children and Adults with Moderate to Severe Vernal Keratoconjunctivitis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Investigated Drugs:
    • Tacrolimus Monohydrate
    • Ciclosporin
    Bulgaria France Greece Italy Spain

  • Testing Intralymphatic Allergen Immunotherapy for Teenagers and Adults with Grass Pollen Allergy Causing Hay Fever or Asthma

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Conjunctivitis allergic
    Italy
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!